Status:
UNKNOWN
Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential Therapy
Lead Sponsor:
Fu Jen Catholic University Hospital
Conditions:
Helicobacter Pylori
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
This study aims to compare the efficacy of the current standard first-line anti-helicobacter pylori regimen, extended proton pump inhibitor-based sequential therapy, with that of vonoprazan-based trip...
Detailed Description
Helicobacter pylori infection is a well-established risk factor for peptic ulcer disease and gastric cancer. It's now a consensus of experts that H.pylori infection should be treated once it is recogn...
Eligibility Criteria
Inclusion
- Patients with H.pylori infection who was over 20 years old and agree to participate in the trial will be recruited.
Exclusion
- Who had received helicobacter pylori eradication before
- Who are known to be allergic to any drug used in this trial
- Pregnant women
- Who are refuse to participate in the trial for any reason
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
628 Patients enrolled
Trial Details
Trial ID
NCT05371249
Start Date
December 1 2021
End Date
February 28 2024
Last Update
August 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fu Jen Catholic University Hospital
New Taipei City, Taiwan, 243